Financhill
Back

DermTech Quote, Financials, Valuation and Earnings

DermTech Price Quote

$0.0300
+0.0010 (+3.45%)
(Updated: September 16, 2024 at 3:55 PM ET)

DermTech Key Stats

Sell
17
DermTech (DMTKQ) is a Sell

Day range:
$0.0290 - $0.0380
52-week range:
$0.0070 - $1.9900
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.06
P/B ratio:
0.03%

Volume:
194.8K
Avg. volume:
258K
1-year change:
-98.51%
Market cap:
$1M
Revenue:
$15.3M
EPS:
$-2.7

How Much Does DermTech Make?

  • How Much Are DermTech's Sales Annually?
    DMTKQ Revenues are $15.3M
  • How Much Profit Does DermTech's Make A Year?
    DMTKQ net income is -$100.9M

Is DermTech Growing As A Company?

  • What Is DermTech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is DermTech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

DermTech Stock Price Performance

  • Did DermTech Stock Go Up Last Month?
    DermTech share price went down by -37.09% last month
  • Did DMTKQ's Share Price Rise Over The Last Year?
    DMTKQ share price fell by -98.51% over the past 1 year

What Is DermTech 52-Week High & Low?

  • What Is DermTech’s 52-Week High Share Price?
    DermTech has traded as high as $1.9900 over the past 52 weeks
  • What Is DermTech’s 52-Week Low Share Price?
    DermTech has traded as low as $0.0070 over the past 52 weeks

DermTech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy DermTech?

  • How Much Debt Does DermTech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does DermTech Have?
    Cash and short term investments quarterly total is $39M
  • What Is DermTech’s Book Value Per Share?
    Book value per share is 1.14

Is DermTech Cash Flow Positive?

  • What Is DMTKQ Cash Flow From Operations?
    Cash flow from operations (TTM) is -$72.1M
  • What Is DermTech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.3M
  • What Is DermTech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $45.9M

DermTech Return On Invested Capital

  • Is Management Doing A Good Job?
    DMTKQ return on invested capital is -122.59%
  • What Is DermTech Return On Assets?
    ROA measures how assets are converting to revenues and is -64.3%
  • What Is DMTKQ Return On Equity?
    ROE is a measure of profitability and is -122.59%

DermTech Earnings Date & Stock Price

  • What Is DermTech's Stock Price Today?
    A single share of DMTKQ can be purchased today for 0.0290
  • What Is DermTech’s Stock Symbol?
    DermTech trades on the otcm under the ticker symbol: DMTKQ
  • When Is DermTech’s Next Earnings Date?
    The next quarterly earnings date for DermTech is scheduled on September 17, 2024
  • When Is DMTKQ's next ex-dividend date?
    DermTech's next ex-dividend date is September 16, 2024
  • How To Buy DermTech Stock?
    You can buy DermTech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

DermTech Competitors

  • Who Are DermTech's Competitors?
    Below is a list of companies who compete with DermTech or are related in some way:
    • Delcath Systems Inc (DCTH)
    • iSpecimen Inc (ISPC)
    • 23andMe Holding Co (ME)
    • Progyny Inc (PGNY)
    • RadNet Inc (RDNT)

DermTech Dividend Yield

  • What Is DMTKQ Dividend Yield?
    DermTech’s dividend yield currently is 0%
  • What Is DermTech’s Payout Ratio?
    DermTech’s payout ratio is 0%
  • When Did DermTech Last Pay A Dividend?
    The latest dividend pay date is September 16, 2024
  • What Is DermTech’s Dividend Per Share?
    DermTech pays a dividend of $0.0000 per share

DermTech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.7%
Revenue: 10.58% -1.41%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 1.5000
Upside from Last Price: 5072.41%

Major Shareholders

  • How many DMTKQ shares are owned by institutional investors?
    2M DMTKQ shares are owned by institutional investors
  • How many DMTKQ shares are owned by insiders?
    3.4M DMTKQ shares are owned by insiders